Progesterone-Receptor Antagonist ZK 230211
Cancer Terms ->
Drugs and Chemicals ->
Pharmacologic Substance ->
Hormone Antagonist ->
Anti-Progestin -> Progesterone-Receptor Antagonist ZK 230211
Progesterone-Receptor Antagonist ZK 230211 Definition
An orally bioavailable pentafluoroethyl derivative of a mifepristone-related steroid with antiprogestagenic activity. Lonaprisan is a pure, highly receptor-selective progesterone receptor (PR) antagonist; binding of this agent to PRs inhibits PR activation and the associated proliferative effects. Unlike many other antiprogestins such as mifepristone, this agent does not appear to convert to an agonist in the presence of protein kinase A (PKA) activators and shows high antiprogestagenic activity on both progesterone receptor (PR) isoforms PR-A and PR-B.
Progesterone-Receptor Antagonist ZK 230211 Synonyms
Lonaprisan, 11 beta-(4-acetylphenyl)-20,20,21,21,21-pentafluoro-17-hydroxy-19-nor-17 alpha-pregna-5,9-dien-3-one, BAY86-5044, LONAPRISAN, Progesterone Receptor Antagonist ZK 230211, ZK 230211, ZK-PRA
Terms in Progesterone-Receptor Antagonist ZK 230211 category
Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods
No reproduction or republication permitted.